Your browser doesn't support javascript.
loading
Association Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.
Xie, Shao-Hua; Fang, Rui; Huang, Mingtao; Dai, Juncheng; Thrift, Aaron P; Anderson, Lesley A; Chow, Wong-Ho; Bernstein, Leslie; Gammon, Marilie D; Risch, Harvey A; Shaheen, Nicholas J; Reid, Brian J; Wu, Anna H; Iyer, Prasad G; Liu, Geoffrey; Corley, Douglas A; Whiteman, David C; Caldas, Carlos; Pharoah, Paul D; Hardie, Laura J; Fitzgerald, Rebecca C; Shen, Hongbing; Vaughan, Thomas L; Lagergren, Jesper.
Afiliação
  • Xie SH; Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. Electronic address: shaohua.xie@ki.se.
  • Fang R; Department of Epidemiology and Biostatistics, International Joint Research Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Huang M; Department of Epidemiology and Biostatistics, International Joint Research Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Dai J; Department of Epidemiology and Biostatistics, International Joint Research Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention, and Treatment, Collaborative Innovation
  • Thrift AP; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas; Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Anderson LA; Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
  • Chow WH; Department of Epidemiology, MD Anderson Cancer Center, Houston, Texas.
  • Bernstein L; Department of Population Sciences, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Gammon MD; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.
  • Risch HA; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut.
  • Shaheen NJ; Division of Gastroenterology and Hepatology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina.
  • Reid BJ; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Wu AH; Department of Preventive Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.
  • Iyer PG; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Liu G; Pharmacogenomic Epidemiology, Ontario Cancer Institute, Toronto, Ontario, Canada.
  • Corley DA; Division of Research, Kaiser Permanente Northern California, Oakland, California.
  • Whiteman DC; Cancer Control, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Caldas C; Cancer Research UK, Cambridge Institute, Cambridge, United Kingdom.
  • Pharoah PD; Department of Oncology, University of Cambridge, Cambridge, United Kingdom; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Hardie LJ; Division of Epidemiology, Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom.
  • Fitzgerald RC; Medical Research Council Cancer Unit, Hutchison-Medical Research Council Research Centre, University of Cambridge, Cambridge, United Kingdom.
  • Shen H; Department of Epidemiology and Biostatistics, International Joint Research Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention, and Treatment, Collaborative Innovation
  • Vaughan TL; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Lagergren J; Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.
Clin Gastroenterol Hepatol ; 18(12): 2701-2709.e3, 2020 11.
Article em En | MEDLINE | ID: mdl-31756444
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esôfago de Barrett / Neoplasias Esofágicas / Adenocarcinoma Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Clin Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esôfago de Barrett / Neoplasias Esofágicas / Adenocarcinoma Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Clin Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos